BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12566932)

  • 1. Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia.
    Lai IC; Liao DL; Bai YM; Lin CC; Yu SC; Chen JY; Wang YC
    Neuropsychobiology; 2002; 46(4):173-5. PubMed ID: 12566932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.
    Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.
    Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
    Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.
    Woo SI; Kim JW; Rha E; Han SH; Hahn KH; Park CS; Sohn JW
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):469-74. PubMed ID: 12109967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative association between catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and persistent tardive dyskinesia in schizophrenia.
    Lai IC; Wang YC; Lin CC; Bai YM; Liao DL; Yu SC; Lin CY; Chen JY; Liou YJ
    J Neural Transm (Vienna); 2005 Aug; 112(8):1107-13. PubMed ID: 15583953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients.
    Liou YJ; Liao DL; Chen JY; Wang YC; Lin CC; Bai YM; Yu SC; Lin MW; Lai IC
    Neuromolecular Med; 2004; 5(3):243-51. PubMed ID: 15626824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.
    Liou YJ; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Mo GH; Lai IC
    Am J Med Genet B Neuropsychiatr Genet; 2009 Mar; 150B(2):239-42. PubMed ID: 18548510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.
    Liou YJ; Wang YC; Chen JY; Bai YM; Lin CC; Liao DL; Chen TT; Chen ML; Mo GH; Lai IC
    Psychiatry Res; 2007 Dec; 153(3):271-5. PubMed ID: 17669510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
    Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
    Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
    Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
    Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
    Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia.
    Chong SA; Tan EC; Tan CH; Mythily ; Chan YH
    Am J Med Genet B Neuropsychiatr Genet; 2003 Jan; 116B(1):51-4. PubMed ID: 12497614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. There is no evidence for an association between the serotonin receptor 3A gene C178T polymorphism and tardive dyskinesia in Korean schizophrenia patients.
    Kang SG; Lee HJ; Yoon HK; Cho SN; Park YM; Kim L
    Nord J Psychiatry; 2013 Jun; 67(3):214-8. PubMed ID: 23126479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analysis of a neural nitric oxide synthase gene polymorphism and antipsychotics-induced tardive dyskinesia in Chinese schizophrenic patients.
    Wang YC; Liou YJ; Liao DL; Bai YM; Lin CC; Yu SC; Chen JY
    J Neural Transm (Vienna); 2004 May; 111(5):623-9. PubMed ID: 15088155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of
    Boiko AS; Ivanova SA; Pozhidaev IV; Freidin MB; Osmanova DZ; Fedorenko OY; Semke AV; Bokhan NA; Wilffert B; Loonen AJM
    World J Biol Psychiatry; 2020 Jan; 21(1):72-77. PubMed ID: 30623717
    [No Abstract]   [Full Text] [Related]  

  • 18. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
    Zai CC; Hwang RW; De Luca V; Müller DJ; King N; Zai GC; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):639-51. PubMed ID: 16959057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
    Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
    Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesia.
    Park SW; Lee JG; Kong BG; Lee SJ; Lee CH; Kim JI; Kim YH
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):433-9. PubMed ID: 19457211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.